Citadel Advisors’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
120,874
-26,423
| -18% | -$275K | ﹤0.01% | 3085 |
|
|
2025
Q1 | $1.94M | Sell |
147,297
-167,703
| -53% | -$2.21M | ﹤0.01% | 2622 |
|
|
2024
Q4 | $5.64M | Sell |
315,000
-60,767
| -16% | -$1.09M | ﹤0.01% | 1703 |
|
|
2024
Q3 | $5.76M | Buy |
+375,767
| New | +$5.76M | ﹤0.01% | 1652 |
|
|
2024
Q2 | – | Sell |
-3,318
| Closed | -$64.7K | – | 6672 |
|
|
2024
Q1 | $64.7K | Sell |
3,318
-14,252
| -81% | -$278K | ﹤0.01% | 5243 |
|
|
2023
Q4 | $363K | Sell |
17,570
-1,585
| -8% | -$32.8K | ﹤0.01% | 4048 |
|
|
2023
Q3 | $609K | Buy |
19,155
+644
| +3% | +$20.5K | ﹤0.01% | 3536 |
|
|
2023
Q2 | $622K | Buy |
18,511
+1,588
| +9% | +$53.4K | ﹤0.01% | 3430 |
|
|
2023
Q1 | $706K | Buy |
16,923
+10,840
| +178% | +$452K | ﹤0.01% | 3521 |
|
|
2022
Q4 | $206K | Sell |
6,083
-22,184
| -78% | -$752K | ﹤0.01% | 4677 |
|
|
2022
Q3 | $1.39M | Buy |
28,267
+19,196
| +212% | +$945K | ﹤0.01% | 3094 |
|
|
2022
Q2 | $357K | Sell |
9,071
-1,140
| -11% | -$44.9K | ﹤0.01% | 4469 |
|
|
2022
Q1 | $377K | Buy |
10,211
+2,381
| +30% | +$87.9K | ﹤0.01% | 4727 |
|
|
2021
Q4 | $765K | Buy |
7,830
+4,368
| +126% | +$427K | ﹤0.01% | 4133 |
|
|
2021
Q3 | $432K | Sell |
3,462
-548
| -14% | -$68.4K | ﹤0.01% | 4687 |
|
|
2021
Q2 | $503K | Sell |
4,010
-2,832
| -41% | -$355K | ﹤0.01% | 4711 |
|
|
2021
Q1 | $929K | Buy |
6,842
+2,996
| +78% | +$407K | ﹤0.01% | 4004 |
|
|
2020
Q4 | $350K | Buy |
3,846
+3,277
| +576% | +$298K | ﹤0.01% | 4114 |
|
|
2020
Q3 | $42K | Buy |
+569
| New | +$42K | ﹤0.01% | 4423 |
|
|
2020
Q2 | – | Sell |
-56,511
| Closed | -$4.09M | – | 5194 |
|
|
2020
Q1 | $4.09M | Buy |
+56,511
| New | +$4.09M | ﹤0.01% | 1600 |
|
|
2019
Q1 | – | Sell |
-739
| Closed | -$59K | – | 4943 |
|
|
2018
Q4 | $59K | Buy |
+739
| New | +$59K | ﹤0.01% | 4088 |
|